Nuvilex Retains Dawson James Financial Services and Moves to Finalize SG Austria Asset Acquisition

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX), an emerging biotechnology provider of cell and gene therapy solutions, today announced that it has executed a consulting agreement with Dawson James Financial Services, Inc. The agreement is seen as a key step as the company moves forward with closing the SG Austria asset acquisition.
MORE ON THIS TOPIC